Reduced fat oxidation rates during submaximal exercise in boys with cystic fibrosis  by Nguyen, Thanh et al.
www.elsevier.com/locate/jcf
Journal of Cystic Fibrosis 13 (2014) 92–98Original Article
Reduced fat oxidation rates during submaximal exercise in boys with
cystic ﬁbrosis☆
Thanh Nguyen a, Joyce Obeid a, Jeff M. Baker b,c, Tim Takken a,d, Linda Pedder e,
Gianni Parise b,c, Brian W. Timmons a,⁎
a Child Health & Exercise Medicine Program, Department of Pediatrics, McMaster University, Hamilton, ON, Canada
b Exercise Metabolism Research Group, Department of Kinesiology, McMaster University, Hamilton, ON, Canada
c Department of Kinesiology, McMaster University, Hamilton, ON, Canada
d Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands
e Cystic Fibrosis Clinic, McMaster Children's Hospital, Hamilton, ON, Canada
31 January 2013; 13 May 2013; 15 May 2013
Available online 1 July 2013Abstract
Background: Exercise is a viable form of therapy for children with cystic ﬁbrosis (CF). Understanding the energy sources used during exercise
would aid CF patients in obtaining proper nutrition in order to sustain an active lifestyle.
Methods: Six boys with CF (mean age ± SD: 14.8 ± 2.3 yrs, FEV1: 99 ± 18% predicted) and six matched controls (14.0 ± 2.2 yrs) completed a
session of two 30 min bouts of cycling at an intensity set at 50% peak mechanical power. Rates of total fat and carbohydrate (CHO) oxidation were
calculated from expired gases. Plasma insulin, glucose and free fatty acid (FFA) were determined before, during and at the end of the exercise.
Results: Rates of fat oxidation (expressed in mean mg × kg body weight−1 × min−1 ± SD) were signiﬁcantly lower in children with CF (5.7 ± 1.6)
compared to controls (8.6 ± 1.8, p b 0.05). Children with CF also had lower values than controls in amount of fat oxidized (CF: 17.3 ± 5.0 g, controls:
26.1 ± 5.9 g, p b 0.05) and percent of total energy expenditure from fat (CF: 32 ± 6%, controls: 43 ± 7%, p b .0.05), but a higher contribution
from CHO (CF: 68 ± 6%, controls: 57 ± 7% p b .0.05). Plasma FFA was signiﬁcantly lower in children with CF compared to controls during
(CF: 252.5 ± 117.9 μM, controls: 602.2 ± 295.6) and at the end of exercise (CF: 430.9 ± 180.6, controls: 1147.5 ± 473.5). There were no differences
in the rates of CHO oxidation, insulin or glucose between groups.
Conclusion: Fat metabolism during exercise is impaired in boys with CF and may be attributed to an inability to mobilize FFA.
© 2013 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Substrate utilization; Free fatty acids; Cycling; Cystic ﬁbrosis1. Introduction
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http://dx.doi.org/10.1016/j.jcf.2013.05.014channel in the pancreas inhibit pancreatic lipase and bicarbon-
ate secretion leading to poor lipid digestion and malabsorption
of properly digested lipids [1]. Even with pancreatic enzyme
replacement therapy, lipid malabsorption is still evident with
only 80–90% of lipid ingested being absorbed, whereas normal
lipid absorption is ~95% [2]. Due to these issues with lipid
absorption, a high lipid diet is promoted for its high caloric
density [3] emphasizing the importance of fat as a fuel, and in
overall CF nutrition.
Malnutrition is thought to be the primary explanation for
impaired growth traditionally observed in CF patients [4].
Whereas impaired growth is only evident in a small proportionby Elsevier B.V. All rights reserved.
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5th percentile for height and ~7% are below the 5th percentile
for weight [5] – between 25 and 35% of Canadian adults with
CF are considered underweight [5]. These findings suggest that
therapeutic intervention strategies should begin during early
childhood development.
Exercise is thought to be an excellent form of therapy for the
CF population [6], with evidence that greater fitness and physical
activity are related to increased chances of survival and a slower
decline in pulmonary function, respectively [7–9]. One of the
clinical strengths in exercise therapy for CF patients lies in the
ability to improve fitness and pulmonary function [6,10–12].
However, there is very little information regarding the impact of
exercise on fuel metabolism in children with CF. Since children
with CF experience malnutrition that results in alternative dietary
requirement in regards to fat, understanding substrate utilization,
particularly fat utilization, during exercise would provide valuable
information to guide patients with respect to dietary considerations
to support an active lifestyle. Greater understanding of substrate
utilization during exercise may also inform appropriate nutritional
intake contributing to improved growth rates.
Limited research studying substrate utilization during exercise
in patients with CF has been conducted and the results are
conflicting. One study involving 10 children and young adults has
shown no differences between CF patients and controls during
exercise [13]. Conversely, two other studies reported a higher
proportion of carbohydrates (CHO) oxidized during exercise in a
group of CF patients, comprised of both children and young adults
or children only [14,15], indicating a greater reliance on CHO
utilization rather than fat utilization during exercise. However, all
of these studies reported only the respiratory exchange ratio (RER)
and did not calculate oxidation rates of fat or carbohydrate to
assess substrate utilization. The objectives of this study were to
determine (1) whether substrate utilization, in particular the use of
fat, during submaximal exercise is altered and (2) the effect of
exercise on plasma insulin, glucose and free fatty acids (FFA) in
children with CF compared to healthy control children.
2. Methods
2.1. Participants
Six clinically stable males with CF and six control males
participated in the study. Children with CF were recruited from the
McMaster Pediatric Cystic Fibrosis clinic at the McMaster
Children's Hospital. Patients that could not perform reproducible
pulmonary function tests were excluded from the study. Recruit-
ment took place during the weekly outpatient pediatric CF clinic.
Patients that met the inclusion criteria were approached by the
clinic doctor, nurse, physiotherapist, dietitian or child life specialist
and asked if they would be interested in hearing about an exercise
study. Families who said “yes” were given a detailed synopsis
about the study by the research coordinator and asked if they were
interested in being contacted further. Families who were interested
filled out a consent-to-contact form. From our experience, we
found CF patients who were engaged in physical activity or sports
were more likely to participate in the study. In the years ofrecruitment (2008 & 2009), our clinic followed an average of 93
patients annually; 40 of these patients were males and of these, 19
were in the age range of 9 to 17 years. Healthy children with no
known chronic illness and not taking any medication were
included in the study as controls. Control boys were recruited as
friends of a CF patient or from the local community by the use of
flyers that were distributed to schools and placed in public areas
(e.g., recreation centers and libraries). Children with CF and
controls were matched by sex and biological age, as determined by
estimated years from the age of peak height velocity (PHV) [16].
The study was approved by the Hamilton Health Science/Faculty
of Health Science Research Ethics Board. Consent and assent were
obtained from parents/guardian and children, respectively, before
induction into the study.2.2. Experimental design
2.2.1. Visit 1
Visit 1 consisted of standard measures of standing height
measured to the nearest 0.1 cm using a calibrated stadiometer
and body mass measured to the nearest 0.1 kg using digital scale
(BWB-800, Tanita Corporation). A bioelectric impedance analyzer
(BIA 101A, RJL system) was used to assess body composition for
descriptive purposes only. Fat free mass (FFM) was calculated
using an age-specific BIA equation [17] and percent body fat was
calculated as [(Body weight − FFM) / body weight] × 100.
Pulmonary function (FEV1) was assessed using the Vmax29
SensorMedics flow volume loop program. Peak mechanical power
(PMP) and VO2peak (Vmax29, SensorMedics) were determined
using the McMaster All-Out Progressive Continuous Cycling Test
on a mechanically braked cycle ergometer (Fleisch–Metabo) as
previously described [18].2.2.2. Visit 2
Visit 2 occurred on a separate day and at least two days after
the first visit to avoid residual effects from the previous exercise
session. In preparation for this visit participants were asked to:
1) refrain from any food or liquid consumption, except water, for
3 h prior to the visit, 2) refrain from eating foods such as pizza,
burgers, French fries, etc, the day before and day of the visit, and
3) not participate in any strenuous physical activity 24 h before the
visit. Visit 2 consisted of two 30 min bouts of cycling with 6 min
of rest between bouts. The participant cycled at a constant pace of
60 rpm at an intensity set at 50% PMP. Breath-by-breath gas
exchange (O2 and CO2) was assessed (Vmax29, SensorMedics)
for 6 min at 12–18 min (EX1) and at 23–29 min (EX2) of the
first 30 min bout of exercise, and at 12–18 min (EX3) and 23–
29 min (EX4) of the second 30 min bout of exercise. The last
3 min of each gas collection period was averaged and used for
analysis. An indwelling catheter was placed in an arm vein of the
participant after 10 min of supine rest before exercise com-
menced. Blood samples were collected before exercise (REST), at
the mid-point of exercise after the first 30 min (MID), and
immediately at the end of exercise after the second 30 min (END).
Blood samples were processed to extract plasma and stored at
–80 °C until analysis.
Table 1
Participants' characteristics.
CF
(n = 6)
Controls
(n = 6)
P values
Age 14.8 ± 2.3 14.0 ± 2.2 0.545
Age range (11.4–17.1) (10.0–16.2)
Estimated years from PHV 0.6 ± 2.0 0.6 ± 2.1 0.989
Height percentile 45.9 ± 25.9 80.2 ± 19.3 0.065
Weight percentile 45.9 ± 20.1 62.3 ± 22.1 0.212
Body fat (%) 19.3 ± 6.2 16.2 ± 8.4† 0.492
VO2peak (ml/kg/min)* 50.3 ± 3.8 54.9 ± 3.0 0.046
FEV1 (% predicted) 99 ± 18 101 ± 13 0.489
Relative intensity (%) 61.7 ± 3.0 62.8 ± 4.9 0.665
Values are expressed in mean ± SD. CF: Cystic fibrosis, PHV: Peak height
velocity, VO2peak: peak oxygen consumption, FEV1; Force expiratory volume in
1 s. *Significant difference between groups. †n = 5. Height and weight percentile
reference values were obtained from Stature-for-age and Weight-for-age data files
from the Centre and Disease Control [28], respectively. Percent body fat was
calculated using an age-specific BIA equation from Schaefer et al. [17]. Percent
FEV1 predicted were calculated using reference values based on age- and height-
specific equation from Wang et al. [29].
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Rates of whole body fat and CHO oxidation were calculated
using the following equations [19]:
FATtotal g=minð Þ ¼ –1:70 V˙ CO2 1=minð Þ þ 1:69 V˙O2 1=minð Þ
CHOtotal g=minð Þ ¼ 4:59 V˙ CO2 1=minð Þ−3:23 V˙O2 1=minð Þ:
The energy potentials of fat (9.75 kcal/g) and CHO
(3.87 kcal/g) were used to calculate energy expenditure (EE)
and the energy yield from each macronutrient, and expressed as a
percent of EE. The contribution of protein to EEwas considered to
be negligible compared to that of fat and CHO and was, therefore,
ignored. In addition, the amount of fat and CHO oxidized
(expressed in grams) was determined using area under the curve
(AUC) based on oxidation rates at EX1, EX2, EX3 and EX4.
2.4. Blood analyses
Plasma insulin was analyzed using commercially available
enzyme-linked immunosorbant assay (ELISA) kits (Invitrogen
Corporation). Plasma glucose was analyzed using assay colori-
metric kits (Cayman Chemical Company). Plasma free fatty acids
were analyzed using ELISA kits (BioZen, Inc.). The coefficient
of variation for insulin, glucose and FFA was 3.1%, 2.8% and
4.1%, respectively. All exercise values were adjusted for changes
in plasma volume [20].
2.5. Statistical analysis
Data were tested for normal distribution using Shapiro–Wilk
test (SPSS version 17.0, p b 0.05). Height percentiles were not
normally distributed and were analyzed using a Mann–Whitney U
test (p b 0.05). Age, estimated years from PHV, weight percen-
tiles, % body fat, VO2peak, FEV1, and relative intensity were
normally distributed and compared between groups using an
independent t-test (p b 0.05). Fat and CHO oxidation rates,
grams oxidized, % of total EE, glucose and FFA were normally
distributed, while insulin values were not normally distributed.
Insulin values were log transformed to achieve normal distribution
and log values used for analyses. EE and grams of fat and CHO
oxidation were compared between groups using an independent
t-test. One-way repeated measure ANOVAs (Statistica version 5.0,
p b 0.05) were performed on FATtotal, CHOtotal, % fat of total EE,
% CHO of total EE, insulin, glucose and FFA concentrations
separately for children with CF and controls to determine the effect
of exercise. Two-way repeated measure ANOVAswere performed
on the same variable as in the one-way ANOVA analyses to
determine group differences. The two factors examinedwere group
(two levels: CF, Control) × time (four levels: EX1, EX2, EX3,
EX4 or three levels: REST, MID, END, depending on variable). If
a main effect for group and/or a group × time interaction was
present, Tukey's HSD post hoc analyses were performed to test for
differences between means. Significance was set at p ≤ 0.05.
Values are expressed as mean ± SD, unless stated otherwise.
Effect sizes were determined for any significant differencesbetween children with CF and controls using means, pooled
standard deviations (SD) and the following equation: Effect size =
(Mean of control group − Mean of CF group) / SDpooled.
3. Results
3.1. Participants
Participant characteristics are presented in Table 1. There
were no significant differences between groups in any of the
characteristic variables, except for VO2peak. Children with CF
were less fit than the control group. Both groups were working
at the same relative intensity during the experimental session.
3.2. Oxidation rates
In children with CF, FATtotal oxidation rates (expressed in
meanmg × kg body weight−1 × min−1 ± SD) at EX3 (6.3 ± 2.1,
p b 0.05) and at EX4 (6.8 ± 1.8, p b 0.05) were higher than at
EX1 (4.5 ± 1.3) (Fig. 1.A). FATtotal at EX2 (5.4 ± 2.0) and at
EX1were similar in children with CF. In healthy controls, FATtotal
oxidation rates at EX2 (8.7 ± 2.9, p b 0.01), EX3 (9.2 ± 2.2,
p b 0.01) and EX4 (10.7 ± 1.4, p b 0.001) were higher than at
EX1 (5.9 ± 1.7) (Fig. 1.A). Children with CF had a significantly
lower average rate of FATtotal oxidation compared to controls
(CF: 5.7 ± 1.6, controls: 8.6 ± 1.8, p b 0.05) (Fig. 1.C), and
oxidized a lower amount of fat (AUC) compared to controls
(CF: 17.3 ± 5.0 g, controls: 26.1 ± 5.9 g, p b 0.05) (Fig. 1.E).
The effect sizes between the two groups for fat oxidation rate and
fat oxidized were 1.32 and 1.26, respectively. CHOtotal oxidation
rates (expressed in meanmg × kg bodyweight−1 × min−1 ± SD)
did not change during exercise for children with CF (EX1: 32.6 ±
4.8, EX2: 31.6 ± 4.0, EX3: 30.5 ± 4.0, EX4: 29.6 ± 7.2), while
in controls, values at EX4 (23.7 ± 1.5) were lower than at EX1
(32.9 ± 5.0, p b 0.01) (Fig. 1.B). There was no difference in the
average oxidation rate of CHOtotal between children with CF and
controls (CF: 31.1 ± 3.8, controls: 28.3 ± 3.2) (Fig. 1.D) or in the
Fig. 1. (A) Fat oxidation rates. (B) Carbohydrate oxidation rates. (C) Average fat oxidation rates (D) Average carbohydrate oxidation rates. (E) Amount of fat
oxidized. (F) Amount of carbohydrates oxidized. Values are expressed in mean ± SD for graphs A and B. Values are expressed in median, 25th and 27th percentile,
and range for graphs C–F. CF: Cystic fibrosis. Amount of substrate oxidized was determined using area under the curve. Significantly different from rest: *p b 0.05,
**p b 0.01. ***p b 0.001. Significantly different between groups, #p b 0.05.
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10.9 g) (Fig. 1.F).
3.3. Energy yield
In children with CF, the average EE was 566 ± 160 kcal. In
controls, the average EE was 624 ± 162 kcal. We also compared
EE normalized to both FFM and body weight. Because body
composition (i.e., % body fat) was similar between the groups
these comparisons gave identical results. Therefore, we report EE
normalized to body weight to maintain consistency with substrate
data. Values were not significantly different (p = 0.30) between
groups (CF: 11.2 ± 1.0 kcal/kg body weight vs. controls: 11.2 ±
1.3 kcal/kg body weight). In children with CF, the percent of EE
from FATtotal at EX4 (37 ± 9%, p b 0.05) was higher than at
EX1 (26 ± 7%), while values at EX2 (30 ± 10%) and EX3(34 ± 10%) were similar to EX1. In controls, the percent of EE
from FATtotal at EX2 (44 ± 15%, p b 0.05), EX3 (44 ± 9%,
p b 0.05), and EX4 (53 ± 2, p b 0.001) were higher than at EX1
(31 ± 9%). In children with CF, the percent of EE fromCHOtotal to
EE at EX4 (63 ± 9%, p b 0.05) was lower than at EX1 (74 ± 7%),
while values at EX2 (70 ± 10%) and EX3 (66 ± 10%) were
similar to EX1. In controls, CHOtotal contribution to EE
significantly decreased at EX2 (56 ± 15%, p b 0.05), EX3
(56 ± 9%, p b 0.05), EX4 (47 ± 2, p b 0.001), compared to
EX1 (69 ± 9%). Between groups, children with CF relied
significantly less on FATtotal (CF: 32 ± 7%, p b .0.05) and more
on CHOtotal (CF: 68 ± 7%, p b .0.05) compared to controls
(fat: 43 ± 7%, CHO: 57 ± 7%) (Fig. 2). The effect size for FATtotal
and CHOtotal contribution to EE was 1.25 for both variables. The
median, 25th and 75th percentiles, and ranges for the CHOtotal
contribution to EE for children with CF and controls were 68.4,
Table 2
Plasma insulin and glucose concentrations before and during exercise in children
with CF and controls.
REST MID END
Insulin (pmol/l)
CF 139.1 (90.7–213.3) 85.5 (65.6–111.3)* 82.0 (64.3–104.5)**
Controls 97.5 (72.9–130.4) 69.1 (45.3–105.3) 82.2 (56.2–120.1)
Glucose (mmol/l)
CF 4.6 ± 0.8 4.1 ± 0.4 4.0 ± 0.5
Controls 4.7 ± 0.5 4.0 ± 0.5* 4.5 ± 0.4
Insulin values are expressed in geometric mean (95% CI). Glucose values are
expressed in mean ± SD. REST: before exercise, MID: mid-way of exercise,
END: end of exercise, CF: Cystic fibrosis. Significantly different from rest:
*p b 0.05, **p b 0.01. There were no differences between groups.
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respectively. The median, 25th and 75th percentiles, and ranges for
the FATtotal contribution to EE for children with CF and controls
were 31.6, 25.0 and 35.5 (24.9–43.6) and 43.2, 34.9 and 50.7
(34.5–51.6), respectively.
3.4. Blood analysis
Insulin — In children with CF, the insulin concentration at
MID (p b 0.05) and END (p b 0.01) was lower than at REST
(p b 0.05 and p b 0.01, respectively), while there was no effect
of exercise on insulin concentrations in controls (Table 2). There
were no differences between groups in insulin concentrations.
Glucose— In children with CF, the glucose concentration did
not change with exercise. In contrast, in controls the concentra-
tion at MID (p b 0.05) was lower than at REST (p b .05) while
concentrations at REST and END were similar (Table 2). There
was no significant difference in glucose concentration between
groups.
Free fatty acid — In children with CF, FFA concentrations
at END (430.9 ± 180.6) were higher than at REST (197.5 ±
89.6 μM, p b 0.01), while concentrations at MID (252.5 ±
117.9) and REST were similar (Fig. 3). Similarly, FFA
concentrations at END (1147.5 ± 473.5, p b 0.001) in controls
were higher than at REST (369.1 ± 178.3 μM), while concen-
trations at MID (602.2 ± 295.6) were not different from REST.
Between children with CF and controls, REST concentrations
were not significantly different. However, children with CF had
significantly lower FFA concentrations at MID (p b 0.05) and
at END (p b 0.001) of exercise compared to controls (Fig. 3).
The effect sizes at MID and at END were 1.24 and 1.41,
respectively.
4. Discussion
The results of the current study suggest that children with CF
have altered fat metabolism during submaximal exercise. Despite
our small sample size, the effect sizes were large. Even in our
patients who were quite healthy, they demonstrated a lower rate
of fat oxidation, lower amount of fat oxidized and a lower
percentage of fat derived EE, compared to healthy controls. ToFig. 2. Percent of energy expenditure contribution of fat and carbohydrates in
children with CF and controls. Values are averages over the 4 three time points and
are expressed as mean. CF: Cystic fibrosis, CHO: Carbohydrate. *Significantly
different between groups, p b 0.05.our knowledge, this is the first study to examine whole body
oxidation rates of fat and CHO during prolonged submaximal
exercise in children with CF. Two prior studies examined
substrate utilization in CF patients comprised of both children
and young adults making it impossible to know the results
specific to the pediatric group; these studies gave conflicting
results [13,14]. Wideman et al. [13] tested 10 CF patients aged
10–22 years who, compared to controls, had similar RER,
indicating a similar balance in the oxidation of fat and CHO
during 20 min of submaximal exercise performed at 50% of their
VO2peak. Conversely, Spicher et al. [14] reported that 13 patients
with CF, aged 8–24 years, had similar RQ (term used by authors)
values after ~10 and ~20 min of exercise but greater RQ values
after ~30 min of submaximal incremental exercise compared to
controls, indicating higher oxidation of CHO relative to fat.
Recently Bongers et al. [15], who tested only patients within the
pediatric age range, also reported higher RER values at the end of
maximal exercise in 22 patients (age range of 11–18 years)
compared to healthy peers. Our results are in agreement with the
findings of Spicher et al. [14] and Bongers et al. [15]. It may be
possible that differences in substrate oxidation in CF patients
become more apparent during exercise lasting 30 min or longer
or with incremental exercise. It is also important to note that the
average EE during exercise was not different between our groups,
so this cannot account for the difference in substrate utilization.
Participants with CF in the current study enjoyed high
fitness levels, although slightly lower than controls. Given the
importance of aerobic fitness as a determinant of fat oxidationFig. 3. Plasma free fatty acids in children with CF and controls. Values are expressed
in mean ± SD CF: Cystic fibrosis. REST: before exercise, MID: mid-way of
exercise, END: end of exercise, Significantly different between groups at the specific
time point indicated: *p b 0.05, **p b 0.001.
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VO2peak (data not shown) and confirmed a significant
difference between the CF and controls in fat oxidation. The
use of steroids by CF patients may also play a role in altered fat
metabolism. In fact, women with Crohn's disease, a chronic
inflammatory bowel disease, using steroids display lower
resting fat oxidation compared to their healthy peers [22]. In
our study, two of the six children with CF were on inhaled
steroids. Re-analysis of the data with only patients not on
steroids resulted in the same difference in fat oxidation rate and
FFA (data not shown), ruling out the use of steroids as a
possible reason for the differences observed. However, we
acknowledge that the small sample size (n = 4) is a limitation
in drawing a firm conclusion with respect to steroid use. It is
also worth mentioning that these data are taken only from boys
and data from girls with CF are needed.
In this study, we also found that the lower rates of fat oxidation
were mirrored by lower plasma FFA concentrations during
exercise. Less FFA mobilization at higher energy demand may
help explain the observed lower rates of fat oxidation in children
with CF. An influx of FFA to the blood during exercise is
attributed to the hormonal stimulation [23] of triglycerol
hydrolysis in adipose tissue [24]. This may suggest either an
impaired lipolysis stimulation, impaired rate of lipid hydrolysis,
or impairment in the translocation of FFA from intracellular to
extracellular compartments during exercise in children with CF.
Given no differences in percentage body fat (as measured by
BIA) between our two groups, it is unlikely that endogenous fat
reserves were a limiting factor in FFA mobilization.
Insulin plays a regulatory role in lipolysis [25]. A decrease
in insulin is required for the promotion of the breakdown of
triglycerides to FFA and occurs during the first 30–40 min of
exercise [26]. We found no differences between groups, but did
observe a decrease in insulin values during exercise from
resting levels in the CF group. Therefore, insulin is not likely to
explain the altered metabolism observed during exercise in our
CF participants.
Children with CF are at risk for developing impaired glucose
metabolism and cystic-fibrosis-related diabetes due to the loss
of pancreatic beta cell function or cell death, and consequently
reduced insulin secretion [27]. In the current study, the
concentration of glucose, rates of CHO oxidation and amount
of CHO oxidized observed in children with CF and controls
were similar. During prolonged exercise, fat is the favored
substrate over CHO [26]. In our control participants, the rate of
CHO oxidation decreased from EX1 to EX4, but this normal
response was not observed in children with CF. Children with
CF may need to maintain high rates of CHO oxidation during
exercise to compensate for an inability to use fat as a fuel.
5. Conclusion
Disease-related differences in exercise metabolism are
important for patients and clinicians to consider in the context
of appropriate nutritional intake to support an active lifestyle.
Our results indicate that for prolonged submaximal exercise,
children with CF can maintain their reliance on CHO as a fuelsource, but fail to upregulate FFA utilization to a similar extent as
healthy children. Determining the mechanisms for this impaired
fat metabolism during exercise is beyond the scope of this study;
however, the lower plasma FFA found in CF participants may
indicate impairment in the mobilization of FFA. Given the
differences in metabolism during exercise, additional research is
needed to better understand substrate partitioning during exercise,
including protein utilization, and nutritional requirements of
patients to sustain a healthy active lifestyle.
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